The Latest Breaking News from Pioneer

The Pioneer 11 probe would serve as a metaphorical blueprint for the Voyager missions.

Will van Aert's Cervelo turn all-yellow or all-green again in 2023?

Calls for a ban as health trusts award ‘insourcing’ contracts worth millions to tackle backlogs

The once popular bar and restaurant has shut its doors

Inside two South Seattle manufacturing plants, work is slowly building back up as the aerospace industry recovers from a disastrous downturn.

Apple CarPlay beams your phone apps onto your car's display. Here's everything you need to know about it.

Income investing with stocks is appealing in a crummy market. After all, why not pocket income from stocks when share-price gains are rare, right?

The building should be completed by next August, with 45 jobs created during construction

Oil stock Pioneer Natural Resources is climbing toward a buy point of a cup base amid surging earnings.

The U.S. Food and Drug Administration (FDA) has approved Bluebird bio’s (NASDAQ:BLUE) lead asset ZYNTEGLO (betibeglogene autotemcel) to treat the underlying genetic cause of beta‑thalassemia in adult and pediatric patients who require regular red blood cell (RBC) transfusions. Bluebird shares traded in a range of $6.13 to $8.18 on a day…

As the second quarter earnings season wraps up, investors looking to earn a passive income in order to balance out high inflation can invest in dividend stocks. With the consumer price index up 9.1% over the past 12 months, consumers are feeling their savings being eaten away by inflation.